Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates

Details for Australian Patent Application No. 2004213149 (hide)

Owner Schering Aktiengesellschaft

Inventors Hillisch, Alexander; Peters, Olaf; Gege, Christian; Scherlitz-Hofmann, Ina; Siemeister, Gerhard; Unger, Eberhard; Regenhardt, Wilko

Agent Davies Collison Cave

Pub. Number AU-A-2004213149

PCT Pub. Number WO2004/074308

Priority 103 07 105.9 19.02.03 DE

Filing date 19 February 2004

Wipo publication date 2 September 2004

International Classifications

C07J 041/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074308 Priority application(s): WO2004/074308

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213150-Modulation of the poliovirus receptor function

2004213148-Antitumoral D-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates